Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI by Simões, Rui V et al.
POSTER PRESENTATION Open Access
Improving the classification of brain tumors in












From 16th International Charles Heidelberger Symposium on Cancer Research
Coimbra, Portugal. 26–28 September 2010
Classifiers based on pattern recognition analysis of MRS(I)
data are becoming important tools for the non-
invasive diagnosis of human brain tumors [1,2]. Here we
investigate the potential interest of perturbation-enhanced
MRSI (PE-MRSI), in this case acute hyperglycemia, during
moderate brain hypothermia [3,4], for improving the
discrimination between mouse brain MRS patterns of glio-
blastoma multiforme (GBM), low grade oligodendro-
glioma (ODG2), and non-tumor brain parenchyma (NT).
Six GBM-bearing mice and two ODG2-bearing mice were
scanned at 7 Tesla by PRESS-MRSI with 12 and 136 ms
echo-time, during euglycemia (Eug) and also during
induced acute hyperglycemia (Hyp), generating altogether
four datasets per animal (echo time + glycemic condition):
12Eug, 136Eug, 12Hyp, and 136Hyp. For classifier devel-
opment, using in-house built software SpectraClassifier 2.0
[5,6], all spectral vectors (spv) selected were unit length
normalized (UL2) and used either as training set (76 GBM
spv, four mice; 70 ODG2 spv, 2 mice; 54 NT spv, 6 mice)
or as independent test set (2 mice, 61 GBM spv and 17
NT spv). All Fisher’s LDA classifiers obtained had very
good descriptive performance when extracting at least 10
features from the training sets as evaluated by Bootstrap-
ping: correctly classified cases ≥ 99 %. Evaluation of pre-
dictive performance with the independent test set clearly
revealed that 12Hyp MRSI-based classifiers with at least 5
features provided the best robustness: balanced error rate
(BER) for spv prediction < 0.9 %. This highlights the
potential interest of perturbation-enhanced MRSI proto-
cols for improving the non-invasive characterization of
brain tumors at a preclinical level.
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